| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2003 | WO2003007952A1 Laminitis in horses |
| 01/30/2003 | WO2003007951A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/30/2003 | WO2003007950A1 (pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators |
| 01/30/2003 | WO2003007949A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 01/30/2003 | WO2003007948A1 Antimalarial agent containing rhodacyanine dye compound |
| 01/30/2003 | WO2003007947A1 Use of 4-[(4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 01/30/2003 | WO2003007945A1 Viral polymerase inhibitors |
| 01/30/2003 | WO2003007944A1 Treatment of macular edema with photodynamic therapy |
| 01/30/2003 | WO2003007943A1 Kinase inhibitors and the use thereof |
| 01/30/2003 | WO2003007942A1 Substituted isoindoles and the use thereof |
| 01/30/2003 | WO2003007941A1 2 pyrrolidone derivatives as prostanoid agonists |
| 01/30/2003 | WO2003007940A1 Lactam and thiolactam derivatives as anesthetic and conscious sedation agents |
| 01/30/2003 | WO2003007938A1 Method for the treatment of atopic dermatitis |
| 01/30/2003 | WO2003007937A1 Antitumor agent containing cyclic polylactic acid |
| 01/30/2003 | WO2003007936A1 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 01/30/2003 | WO2003007935A2 Use of a class of antiviral compounds for production of an agent for the treatment or prevention of a viral infection in the respiratory tract |
| 01/30/2003 | WO2003007934A1 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 01/30/2003 | WO2003007933A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 01/30/2003 | WO2003007932A1 Body fat level controllers |
| 01/30/2003 | WO2003007931A1 Sulfonamide derivatives |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | WO2003007929A1 Amine compounds and inhibiting neurotransmitter reuptake |
| 01/30/2003 | WO2003007928A1 Ascites preventives for poultry |
| 01/30/2003 | WO2003007927A1 Synthesis and functin inhibitors for heat shock proteins |
| 01/30/2003 | WO2003007926A2 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions |
| 01/30/2003 | WO2003007925A1 Therapeutic strategies for prevention and treatment of alzheimer's disease |
| 01/30/2003 | WO2003007924A2 Combinations comprising epothilones and pharmaceutical uses thereof |
| 01/30/2003 | WO2003007923A2 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 01/30/2003 | WO2003007922A2 Pharmaceutical formulation containing an ltb4 antagonist |
| 01/30/2003 | WO2003007921A2 Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases |
| 01/30/2003 | WO2003007920A1 Antihistamine formulations for soft capsule dosage forms |
| 01/30/2003 | WO2003007919A1 Controlled drug delivery systems providing variable release rates |
| 01/30/2003 | WO2003007917A1 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 01/30/2003 | WO2003007916A1 Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| 01/30/2003 | WO2003007915A2 Compositions for treatment of head and neck cancers, and methods of making and using the same |
| 01/30/2003 | WO2003007914A2 Biocompatible polymer containing composition for treatment of prostate cancers |
| 01/30/2003 | WO2003007912A2 Lyophilized formulation comprising olanzapine |
| 01/30/2003 | WO2003007909A2 Cosmetic or dermatological preparations having a long-lasting cooling effect |
| 01/30/2003 | WO2003007907A1 Water-free ubichinon concentrate |
| 01/30/2003 | WO2003007888A2 Fat accumulation-modulating compounds |
| 01/30/2003 | WO2003007883A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007876A2 N-fatty acid-amino acid conjugates and therapeutic uses |
| 01/30/2003 | WO2003007802A2 Pharmaceutical combinations of oxycodone and naloxone |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2003007798A2 Ophthalmic use of 5 fluorourcil |
| 01/30/2003 | WO2003007791A2 Interspinous process distraction system and method with positionable wing and method |
| 01/30/2003 | WO2003002580A8 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity |
| 01/30/2003 | WO2003002522A8 Peptide deformylase inhibitors |
| 01/30/2003 | WO2002092088A3 Novel use of 2h-benzimidazol-2-one, 1,3-dihadro-1-(2{4-{3-(trifluoromethyl}phenyl]-1-piperazinyl}ethyl)- and its physiologically acceptable acid addition salts |
| 01/30/2003 | WO2002089817A3 Anti-virus agent |
| 01/30/2003 | WO2002088079A3 Dual inhibitors of pde 7 and pde 4 |
| 01/30/2003 | WO2002080939A8 Ionene polymers and their use as antimicrobial agents |
| 01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
| 01/30/2003 | WO2002074294A9 Taurine compounds |
| 01/30/2003 | WO2002072078A9 Use of sugar phosphates, amino acids, amino acid analogs, e.g. carbomethoxypropionyl cyanide for reducing weight or diabetes complications |
| 01/30/2003 | WO2002070510A3 Amino dicarboxylic acid derivatives with pharmaceutical properties |
| 01/30/2003 | WO2002069984A3 Use of hyaluronic acid uronides for the treatment of inflammatory processes |
| 01/30/2003 | WO2002069945A3 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 01/30/2003 | WO2002066075A3 Biotin-derivatives and their conjugates with chelating agents |
| 01/30/2003 | WO2002066002A3 Pharmaceutical formulation |
| 01/30/2003 | WO2002064160A8 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 01/30/2003 | WO2002060449A3 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 01/30/2003 | WO2002059129A3 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists |
| 01/30/2003 | WO2002058533A3 Process for determining target function and identifying drug leads |
| 01/30/2003 | WO2002057271A3 Thienopyrimidine-based inhibitors of the src family |
| 01/30/2003 | WO2002056825A3 Composition and method to increase calcium levels in animals |
| 01/30/2003 | WO2002055136A3 Intrasvascular drug delivery device and use therefor |
| 01/30/2003 | WO2002053097A3 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 01/30/2003 | WO2002053096A3 Single therapy and combination therapy involving drugs with target cellular proteins and drugs which target pathogen-encoded proteins |
| 01/30/2003 | WO2002050257A3 Method for the production of polyfructans |
| 01/30/2003 | WO2002049642A3 Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis |
| 01/30/2003 | WO2002047603A3 Use of levosimendan for treating erictile dysfunction |
| 01/30/2003 | WO2002043666A3 Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
| 01/30/2003 | WO2002042423A3 Antisense modulation of src-2 expression |
| 01/30/2003 | WO2002038158A8 Improved treatment |
| 01/30/2003 | WO2002034879A3 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 01/30/2003 | WO2002034243A3 Method for the treatment of neurological and neuropsychological disorders |
| 01/30/2003 | WO2002034242A3 Method for the treatment of neurological and neuropsychological disorders |
| 01/30/2003 | WO2002034200A3 Transdermal therapeutic systems comprising photosensitive active substances |
| 01/30/2003 | WO2002030394A3 Medicinal aerosol formulations |
| 01/30/2003 | WO2002029035A3 Method to alter sugar moieties |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002026215A3 Thermogelling biodegradable aqueous polymer solution |
| 01/30/2003 | WO2002018376A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 01/30/2003 | WO2002018375A1 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof |
| 01/30/2003 | WO2002018351A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 01/30/2003 | WO2002017897A3 Methods for treating tumors using sulfonyl compounds |
| 01/30/2003 | WO2002017858A3 Role of fosb in bone formation |
| 01/30/2003 | WO2002014536A3 Odulating multiple lineage kinase proteins |
| 01/30/2003 | WO2002013873A9 P97-active agent conjugates and their methods of use |
| 01/30/2003 | WO2002013836A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
| 01/30/2003 | WO2002012247A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/30/2003 | WO2002010151A2 Method for producing lipoic acid and dihydrolipoic acid |
| 01/30/2003 | WO2002009719A1 Antitumor agents |
| 01/30/2003 | WO2002007765A3 REGULATORS OF PPARδ(β) AND THEIR USE IN THE TREATMENT OF OBESITY AND INSULIN RESISTANCE |
| 01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/30/2003 | WO2001093849A3 Treatment of gastroesophageal reflux disease using piperidine derivatives |
| 01/30/2003 | WO2001091772A3 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |